Gpi’s strategy for growth and internationalization speeds up.
The Group aims at the blood management sector, and buys high-margin software solutions to make our offering more global and competitive.
Two agreements have been signed in quick succession:
- the purchase of 100% of the French group Medinfo, owner of one of the most competitive and comprehensive software solutions for blood management;
- the purchase of software solutions, mostly oriented to the collection of blood, from the Boston-based Haemonetics, a global corporation listed on the New York Stock Exchange (NYSE).